<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-04-21T08:03:33Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/ojpp.000007">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/ojpp.000007</identifier>
									<datestamp>2018-10-26</datestamp>
									<setSpec>PTZ.OJPP:VOL3</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Mini review on emerging methods of preparation of liposome and its application as Liposome drug delivery systems
										</dc:title><dc:creator>Ateeq Rahman</dc:creator><dc:creator> Veikko Uahengo</dc:creator><dc:creator>Daniel Likius</dc:creator><dc:description>&lt;p&gt;Liposomes, sphere-shaped vesicles consisting of one or more phospholipid bilayers, were fi rst&lt;/p&gt;&lt;p&gt;described in the mid-60s. Nowadays, they are a very useful reproduction, reagent, and device in various&lt;/p&gt;&lt;p&gt;scientifi c disciplines, including medicine, chemistry, biochemistry, colloid science, biology, physics,&lt;/p&gt;&lt;p&gt;biophysics, mathematics and theoretical. After the initial discoveries liposomes have made their way to&lt;/p&gt;&lt;p&gt;the market. Among numerous brilliant new drug delivery systems developed, liposomes characterize an&lt;/p&gt;&lt;p&gt;advanced technology to deliver active molecules to the site of action, and at present, several formulations&lt;/p&gt;&lt;p&gt;are in clinical use. Research on liposome technology has progressed from conventional vesicles to&lt;/p&gt;&lt;p&gt;‘second-generation liposomes’, in which long-circulating liposomes are obtained by modulating the lipid&lt;/p&gt;&lt;p&gt;composition, size, and charge of the vesicle. Liposomes with modifi ed surfaces have also been developed&lt;/p&gt;&lt;p&gt;using several molecules, such as glycolipids or sialic acid. This paper mini review summarizes exclusively&lt;/p&gt;&lt;p&gt;Nano-lipids, its applications in medicine scalable techniques in treating dreadful diseases cancer, AIDS,&lt;/p&gt;&lt;p&gt;paralysis etcand focuses on strengths, respectively, limitations in respect to industrial applicability and&lt;/p&gt;&lt;p&gt;regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.&lt;/p&gt;</dc:description>
										<dc:publisher>Open Journal of Pharmacology and Pharmacotherapeutics - Peertechz Publications</dc:publisher>
										<dc:date>2018-10-26</dc:date>
										<dc:type>Review Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/ojpp.000007</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Ateeq Rahman et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
